2015 NCCN Guideline Updates: New Recommendations for Clinical Practice
Expert panel members highlight the latest NCCN guideline recommendations.
Checkpoint Inhibitors Shine Across Tumor Types at AACR
Immune checkpoint blockade strategies were a central focus of much of the key data presented at AACR.
ASCO, AACR Honor Immunotherapy Pioneer James Allison
James P. Allison, PhD, was recently honored with two prestigious awards: the Science of Oncology Award from ASCO and the Pezcoller Foundationâ€“AACR International Award for Cancer Research.
Later-Line Ruxolitinib Use Produces Ongoing Benefit in Real-World Patients With cGVHD
Orca-T Data With Survival, Tolerability Extends to Older Patients With Hematologic Cancers
Dr Ramdial on Gemcitabine/Clofarabine/Busulfan for Lymphoma Stem Cell Transplant
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies
2 Commerce Drive Cranbury, NJ 08512